Parasite heme–iron complex

The **parasite heme–iron complex** refers to free or loosely bound heme (iron–protoporphyrin IX), a protoporphyrin ring with central Fe2+ or Fe3+, present within blood-feeding parasites, most notably _Plasmodium_ species that cause malaria[4][6][7]. During hemoglobin digestion within the parasite's food vacuole, toxic free heme is released and must be detoxified—most commonly via conversion into the inert crystalline pigment **hemozoin**[2][3][4]. Heme serves as an essential cofactor for various enzymatic processes, but its reactive iron center can mediate oxidative damage, making its regulation and detoxification critical to parasite survival[4][6][7]. Select antimalarial drugs (notably the quinolines and artemisinin class) exert their effect by binding to free heme and inhibiting its detoxification, resulting in accumulation of cytotoxic heme and oxidative stress within the parasite, leading to death[3][4][6]. While heme itself is not a conventional protein receptor, it is a validated non-protein, small molecule/metabolite target in antiparasitic chemotherapy, with the heme–iron complex functioning as both an essential metabolite and a drug target[3][6][7]. The "Parasite heme/Fe complex" is not a standard protein-coding gene or classic receptor/enzyme; rather, it represents a critical molecular species in the biology and treatment of parasitic infections. The term is somewhat imprecise and not a canonical target name, as it includes both dynamic (reactive free heme) and detoxified (hemozoin) forms; therefore, the entry is flagged as needing further standardization[3][4][6][7].

Other names

Parasite heme–Fe complexFree heme (in parasite)Hemin (oxidized form: Fe3+ heme in parasites)Hemozoin (when crystallized/detoxified form)Ferriprotoporphyrin IX (chemical name)β-hematin (synthetic analog of hemozoin)

Inhibition of hemozoin formation (prevents conversion of toxic heme to inert crystal, leads to parasite killing) Direct heme binding (by drug, preventing its detoxification) Oxidative damage (amplified release of reactive oxygen species in the presence of free heme) Alkylation and irreversible modification (e.g., artemisinin forms adducts with heme)